Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

To the Editor We read with interest the article by Hathaway et al and applaud the effort to investigate safety signals of semaglutide. We were, however, concerned that the methods used may suffer from bias.

This post was originally published on this site